Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.

British journal of cancer - 1 Nov 1999

Manning L S, Radin N S

Abstract excerpt

This study describes the effects of the glucolipid synthase inhibitor P4, (DL-threo-1-phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol ), on various functional and phenotypic parameters of 5T33 murine myeloma cells. Cell recovery was reduced by >85% following incubation of the cells for 3 days in the presence of 4 microM P4 (the IC50 concentration). Both cytostatic and cytotoxic inhibition was observed with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Apoptosis
Share to Glucosyltransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycolipids

Share to Histocompatibility Antigens Class II

Share to Morpholines

Share to Multiple Myeloma

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 10576650
DOI: 10.1038/sj.bjc.6690792
PMCID: PMC2362950

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells.PMID 10576650Read ↗

The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.Semantic proximity Read ↗

Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myelomaSemantic proximity Read ↗

Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy.Semantic proximity Read ↗

Flow cytometric measurement of functional and phenotypic P-glycoprotein.Semantic proximity Read ↗

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effectsSemantic proximity Read ↗

Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against MyelomaSemantic proximity Read ↗

Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against MyelomaSemantic proximity Read ↗

Factors Influencing the Abundance of the Side Population in a Human Myeloma Cell LineSemantic proximity Read ↗

B-cell surface phenotypes of proliferating myeloma cells: target antigens for immunotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.